A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy

Phase 1/2 Recruiting 60 enrolled Praxis Precision Medicines

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this trial is to learn about the effect of PRAX-222 in pediatric participants with early onset SCN2A developmental and epileptic encephalopathy (DEE), aged 2 to 18 years.

Timeline

Start: 2023-04-13
Primary completion: 2025-08
Completion: 2027-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PRAX-222	Unknown	—	—

A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy

Summary

Timeline

Drugs

Indications